Landmark ‘Three-Person IVF’ Yields Eight Healthy Children, Offering Hope for Families at Risk of Metabolic Disease
A groundbreaking reproductive technique, known as three-person in vitro fertilization (IVF), is demonstrating remarkable success in preventing the transmission of debilitating and often fatal inherited metabolic diseases. Scientists in Newcastle, U.K., have reported the births of eight healthy children conceived through this innovative process, offering a beacon of hope for families carrying mitochondrial DNA (mtDNA) mutations.
The study, published in The New England Journal of Medicine, highlights that pathogenic variants in mtDNA are a “common cause” of severe inherited metabolic diseases. These mutations can lead to devastating conditions affecting vital tissues in the heart, brain, and muscles, as detailed by the journal Nature.
At the Newcastle Fertility Centre, 22 women with identified pathogenic mtDNA variants underwent a procedure called “pronuclear transfer.” This complex process involves a mitochondrial donation: the nucleus of a fertilized egg carrying “faulty mitochondria” is transferred into a donor egg cell possessing healthy mitochondria. The resulting embryo contains nuclear DNA from both the biological mother and father, alongside the healthy mitochondrial DNA from the donor.
“To see babies born at the end of this is amazing, and to know there’s not going to be mitochondrial disease at the end of that,” a pediatric neurologist at Newcastle University, who co-led one of the studies, reportedly stated during a press briefing.
Of the 22 women who underwent the procedure, eight children were born healthy, with either undetectable or very low levels of mtDNA from the donor detected in their blood. While the vast majority of children thrived, researchers noted a few minor health concerns. One child experienced hyperlipidemia (high cholesterol) and cardiac arrhythmia (irregular heartbeat), conditions that responded to treatment, mirroring the mother’s pre-existing hyperlipidemia during pregnancy. Another child developed infant myoclonic epilepsy, a rare form of epilepsy typically affecting infants between six months and three years old, but experienced “spontaneous remission.”
“At the time of this report, all the children have made normal developmental progress,” the researchers confirmed.
The success of this technique is being hailed as a significant milestone in reproductive medicine. Dr. Zev Williams, director of Columbia University Fertility Center in New York City, emphasized the importance of this research, stating, “This latest research marks an important milestone. Expanding the range of reproductive options … will empower more couples to pursue safe and healthy pregnancies.”
This new scientific advancement promises to “empower more couples to pursue safe and healthy pregnancies,” according to a Columbia fertility expert. The team expressed “cautious optimism” about the long-term implications of this approach, acknowledging the need for continued monitoring of the children as they develop.
For more information on health-related news, visit www.foxnews.com/health.
